{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:52:17Z","timestamp":1763765537441},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.leukres.2005.05.008","type":"journal-article","created":{"date-parts":[[2005,6,25]],"date-time":"2005-06-25T11:38:58Z","timestamp":1119699538000},"page":"103-105","source":"Crossref","is-referenced-by-count":26,"title":["Complete response in a patient with adult T-cell leukemia (ATL) treated with combination of alemtuzumab and pentostatin"],"prefix":"10.1016","volume":"30","author":[{"given":"Farhad","family":"Ravandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Faderl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2005.05.008_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.immunol.15.1.15","article-title":"Human T cell leukemia virus type I (HTLV-I) and human diseases","volume":"15","author":"Uchiyama","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.leukres.2005.05.008_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0168-1702(01)00286-6","article-title":"Treatment of adult T-cell leukaemia\/lymphoma: current strategy and future perspectives","volume":"78","author":"Bazarbachi","year":"2001","journal-title":"Virus Res"},{"key":"10.1016\/j.leukres.2005.05.008_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2005.05.008_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/blood.V79.2.477.477","article-title":"Mutations of the p53 gene in adult T-cell leukemia","volume":"79","author":"Sakashita","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.05.008_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303","volume":"113","author":"Yamada","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2005.05.008_bib6","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","article-title":"Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine","volume":"332","author":"Gill","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2005.05.008_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1470-2045(04)01608-0","article-title":"New therapeutic approaches for adult T-cell leukaemia","volume":"5","author":"Bazarbachi","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.leukres.2005.05.008_bib8","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood.V82.6.1701.1701","article-title":"The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia","volume":"82","author":"Waldmann","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.05.008_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0145-2126(03)00004-3","article-title":"Chronic lymphocytic leukemia (B-CLL) occurring with human immunodeficiency virus (HIV) infection: implications","volume":"27","author":"Ravandi","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2005.05.008_bib10","doi-asserted-by":"crossref","first-page":"594s","DOI":"10.1200\/jco.2005.23.16_suppl.6639","article-title":"Durable complete response (CR) and suppression of the human T-cell leukemia (HTLV-I) viral load with alemtuzumab in refractory adult T-cell leukemia (ATL)","volume":"23","author":"Porcu","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212605002006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212605002006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T23:03:38Z","timestamp":1586300618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212605002006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0145212605002006"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2005.05.008","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}